Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation-Reference-Cited by-同舟云学术

Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation

Published:2008-08 Issue:35 Volume:283 Page:23721-23730
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wilsbacher Julie L.,Zhang Qian,Tucker Lora A.,Hubbard Robert D.,Sheppard George S.,Bamaung Nwe Y.,Fidanze Steve D.,Wang Gary T.,Hu Xiaoming,Davidsen Steven K.,Bell Randy L.,Wang Jieyi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference51 articles.

1. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer

2. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models

3. The insulin-like growth factor-I receptor as a target for cancer therapy

4. Advances towards the Development of ATP-Competitive Small-Molecule Inhibitors of the Insulin-Like Growth Factor Receptor (IGF-IR)

5. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors;Bioorganic Chemistry;2021-10

2. Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance;Molecular Diversity;2019-10-28

3. Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin‐like growth factor‐1 receptor and its downstream pathways;Journal of Cellular and Molecular Medicine;2019-09-11

4. Improving expression of recombinant human IGF-1 using IGF-1R knockout CHO cell lines;Biotechnology and Bioengineering;2016-01-18

5. Preclinical Models of Head and Neck Squamous Cell Carcinoma;Head and Neck Cancer;2016